SHARE
Enlarge / Bottles of Purdue Pharma L.P. OxyContin medication sit on a pharmacy shelf in Provo, Utah, on Wednesday, Aug. 31, 2016.Getty | Bloomberg

The mega-rich family behind the OxyContin-maker Purdue Pharma is back to selling its highly addictive pain killer with underhanded tactics and deceptive advertising—this time in China, via its international company, Mundipharma. Thats all according to a searing new investigation by the Associated Press.

The Sackler family, which owns both Purdue and Mundipharma, is embroiled in litigation in the United States over its alleged role in sparking the countrys epidemic of opioid abuse and overdoses. Thousands of plaintiffs—many state and local governments—claim that Purdue and the Sacklers misled patients, doctors, and regulators on the addictiveness of their drugs, aggressively marketed them, and wooed doctors into over-prescribing them.

While Purdue has since declared bankruptcy and stopped promoting OxyContin in the US, the Sacklers seem to be employing the same detestable practices in China.

Based on documents and interviews with multiple Mundipharma representatives in China, the AP investigation found that reps were at times posing as doctors, providing debunked information that its long-acting opioids are safe and less addictive, and even illegally copying private medical records of patients to inform sales tactics.

When an AP reporter informed one of the Mundipharma reps that some of the marketing information was incorrect, she Read More – Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here